Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling
about
Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationLipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipidsRegulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness.Thromboxane and the thromboxane receptor in cardiovascular disease.Prostaglandins and inflammation.The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis.Mutually opposite signal modulation by hypothalamic heterodimerization of ghrelin and melanocortin-3 receptors.Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif.An eicosanoid-centric view of atherothrombotic risk factorsThromboxane A2 receptor: biology and function of a peculiar receptor that remains resistant for therapeutic targeting.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Light on the structure of thromboxane A₂receptor heterodimers.Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species.F2-isoprostane receptors on hepatic stellate cells.Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice.
P2860
Q26864770-B5D6D1CF-336D-4D98-9FF1-F08CB5DFCC35Q28389004-4824656D-B8D7-4ED1-AE48-47A728683741Q33697758-4783F60C-3321-402C-9F69-74A5786157F4Q33899567-1534AA9C-6A7B-44FC-81B4-7537F3D815DBQ34179727-CF1CC916-C6CD-4E05-87BE-5B77E77AB683Q34228685-346F6D1E-5439-4923-9C21-05FCD7CDE8E7Q35604455-AC14660D-2BFC-46A9-ADAC-9EFC8761305FQ36822598-E8C0E02D-43A5-41A3-AF9D-B96B1D6784A4Q36952174-FAED435E-F132-4F8B-8D1B-6613EA0838EBQ37953820-CC87D692-8821-48FC-A6DA-0DD467078745Q37995534-1299100B-53DB-4CED-9664-3EED1E43DA4AQ38338198-84D577FE-D4D9-4046-AF60-D5F36DF4D532Q39893903-A992E7A7-AFDE-4AA9-96BC-A3A55471F6E8Q46833791-58EDB68C-3610-46A3-BB0B-526970FAC785Q46945532-2722CB49-D9BA-4D8A-9AEA-080359E11DA7
P2860
Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Heterodimerization of the alph ...... enhances isoprostane signaling
@ast
Heterodimerization of the alph ...... enhances isoprostane signaling
@en
type
label
Heterodimerization of the alph ...... enhances isoprostane signaling
@ast
Heterodimerization of the alph ...... enhances isoprostane signaling
@en
prefLabel
Heterodimerization of the alph ...... enhances isoprostane signaling
@ast
Heterodimerization of the alph ...... enhances isoprostane signaling
@en
P2093
P2860
P1476
Heterodimerization of the alph ...... enhances isoprostane signaling
@en
P2093
Albert J Huang
Emer M Smyth
Kevin McGinley
Stephen J Wilson
P2860
P304
P356
10.1016/J.BBRC.2006.11.040
P407
P577
2006-11-16T00:00:00Z